• Record total contract value of A$4.3m in Q4 FY25
• Signed 16 new client agreements across migration technology and Ensight software
• Expanded work with strategic enterprise and OEM partners

Enlitic, a medical technology software company, reported a record total contract value of approximately A$4.3m in Q4 FY25, up from A$3.1m in the previous quarter. This reflects an increase in average contract size, driven by a greater proportion of enterprise and OEM-related agreements, as well as continued execution of the company's commercial strategy. Enlitic signed a total of 16 new client agreements in Q4 FY25, which were of higher average value than new client agreements signed in any singular quarter to date, including both migration technology contracts and Ensight software license agreements. The company also expanded the scope of work across several existing enterprise and OEM relationships, increasing long-term engagement value. While revenue for the quarter was impacted by extended delivery schedules due to expanded project scope, the underlying commercial momentum of the business remains strong. Enlitic continues to demonstrate strong cost discipline and operational efficiency, with further cost reduction measures implemented subsequent to the quarter end expected to deliver approximately US$2.5m in annualised cost savings. The company completed a capital raise via convertible notes for A$8.0m, with the first tranche of A$2.6m completed in December 2025, strengthening the balance sheet with approximately US$2.75m in cash at period end. An additional tranche of A$5.4m via convertible notes is subject to shareholder approval on 4 February 2026.

Enlitic expects revenue in FY26 to be higher than FY25 as the more substantive components of a key project with a major global healthcare customer contribute to higher revenues.

Enlitic is building deeper, higher-value partnerships that support scalable, long-term growth, positioning the company well as it enters FY26. The company continues to review its cost base and will seek further efficiency opportunities in FY26.